BORTOLOTTI, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 6.443
AS - Asia 3.668
EU - Europa 2.211
SA - Sud America 610
AF - Africa 68
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 13.018
Nazione #
US - Stati Uniti d'America 6.329
SG - Singapore 1.329
CN - Cina 1.000
BR - Brasile 469
VN - Vietnam 414
IT - Italia 409
UA - Ucraina 378
HK - Hong Kong 313
DE - Germania 274
FR - Francia 247
GB - Regno Unito 233
TR - Turchia 195
PL - Polonia 150
FI - Finlandia 143
SE - Svezia 115
JP - Giappone 92
IN - India 91
RU - Federazione Russa 77
BD - Bangladesh 62
AR - Argentina 52
CA - Canada 52
MX - Messico 48
ZA - Sudafrica 32
ID - Indonesia 30
NL - Olanda 30
PK - Pakistan 30
IQ - Iraq 29
AT - Austria 28
ES - Italia 26
CO - Colombia 23
EC - Ecuador 19
VE - Venezuela 16
BE - Belgio 14
LT - Lituania 14
AU - Australia 13
CL - Cile 13
CZ - Repubblica Ceca 12
DK - Danimarca 12
SA - Arabia Saudita 9
PH - Filippine 8
PY - Paraguay 8
UZ - Uzbekistan 7
BY - Bielorussia 6
CH - Svizzera 6
GR - Grecia 6
IE - Irlanda 6
IL - Israele 6
MA - Marocco 6
MY - Malesia 6
NP - Nepal 6
PT - Portogallo 6
TN - Tunisia 6
DZ - Algeria 5
IR - Iran 5
JO - Giordania 5
KR - Corea 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
GT - Guatemala 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
ET - Etiopia 3
HU - Ungheria 3
KE - Kenya 3
KW - Kuwait 3
RS - Serbia 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AL - Albania 2
GA - Gabon 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
GY - Guiana 1
JM - Giamaica 1
KZ - Kazakistan 1
LY - Libia 1
ME - Montenegro 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
RE - Reunion 1
RO - Romania 1
SC - Seychelles 1
Totale 13.012
Città #
Singapore 851
Ashburn 639
Woodbridge 602
Fairfield 495
Jacksonville 405
Chandler 360
Houston 360
Santa Clara 359
San Jose 349
Beijing 286
Hong Kong 286
Ann Arbor 283
Cambridge 183
Seattle 183
Wilmington 170
Warsaw 143
Ho Chi Minh City 135
New York 132
Nanjing 122
Izmir 121
Hanoi 100
Los Angeles 100
Tokyo 88
Princeton 82
Dallas 76
Boardman 59
Lauterbourg 59
Helsinki 58
Munich 51
San Diego 48
São Paulo 43
Milan 42
Shenyang 39
Brooklyn 35
Ferrara 35
Tianjin 34
Shanghai 33
Mexico City 32
Nanchang 30
Hebei 29
London 29
Council Bluffs 27
Orem 27
The Dalles 26
Vienna 24
Hefei 23
Da Nang 22
Frankfurt am Main 22
Rio de Janeiro 22
Chennai 20
Rome 20
Chicago 19
Dearborn 19
Changsha 18
Montreal 18
Mountain View 18
Denver 17
Johannesburg 17
Redwood City 17
Buffalo 16
Hangzhou 16
Poplar 16
San Mateo 16
Atlanta 15
Jakarta 15
Manchester 15
Bremen 14
Brussels 14
Guangzhou 14
Haiphong 14
Jiaxing 14
Phoenix 14
Baghdad 13
Jinan 13
Addison 12
Moscow 12
Norwalk 12
Stockholm 12
Turku 12
Boston 11
Copenhagen 11
Amsterdam 10
Biên Hòa 10
Columbus 10
Falls Church 10
Mumbai 10
Ningbo 10
Philadelphia 10
Toronto 10
Bologna 9
Hải Dương 9
Kunming 9
Porto Alegre 9
Bexley 8
Brno 8
Karachi 8
Medellín 8
Naples 8
Orange 8
San Francisco 8
Totale 8.415
Nome #
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 378
Opportunity and challenges of nasal powders: Drug formulation and delivery 374
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 321
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 248
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 243
Conjugation of aspirin with vitamin C: uptake and stability studies 241
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 234
Amphiphilic association systems for amphotericin B delivery 227
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 224
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 222
Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA 218
Amphiphilic association systems for Amphotericin B delivery 214
A novel multicompartimental system based on aminated poly(vinyl alcohol) microspheres/succinoylated pullulan microspheres for oral delivery of anionic drugs 209
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 208
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia 207
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 206
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 205
Photoredox reactions in Cytochrome c and cytochrome c551 198
Characterization of low -molecular-mass trypsin isoinhibitors from oil-rape (Brassica napus var. oleifera) seed 197
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 196
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 193
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 187
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 184
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 178
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 176
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 174
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 171
Preparation and characterisation of thermoresponsive poly [(N-isopropylacrylamide-co-acrylamide-co(hydroxyethyl acrylate)] microspheres as a matrix for the pulsed release of drugs 170
Combination of alginate and cells for skin regeneration 165
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 158
Poly[(N-isopropylacrylamide-co-acrylamide-co-(hydroxyethylmethacrylate)]thermoresponsive microspheres: an accurate method based on solute exclusion technique to determine the volume phase transition temperature 158
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 157
Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections 156
Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs 156
Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors 154
Integral Antioxidant Capacity (IAC) of cosmetic formulations. Determination using photochemiluminescence. 152
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 152
Nasal administration and brain targeting of an antiischemic agent 151
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 150
Preparation and characterization of collagen sponges for dermo-cosmetic applications 150
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 147
Materie Prime: Eccipienti 147
INHIBITION OF BOVINE BETA-TRYPSIN, HUMAN ALPHA-THROMBIN AND PORCINE PANCREATIC BETA-KALLIKREIN-B BY BENZAMIDINE AND ITS BIS-DERIVATIVES, TRIS-DERIVATIVES AND TETRA-DERIVATIVES - THERMODYNAMIC AND MOLECULAR MODELING STUDY 144
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 141
Ex vivo propofol permeation across nasal mucosa: A proof-of-concept study for outpatient light sedation via nasal route 139
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 139
The recovery method influences properties of adenosine derivatives loaded nanospheres 138
Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors 137
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 134
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 126
PRODRUGS, MICRO OR NANOPARTICULATE SYSTEMS AND NASAL ADMNISTRATION AS NON INVASIVE APPROACHES AGAINST BRAIN DISEASES AND AIRBORNE INFECTIONS. LOCO-REGIONAL THERAPY OF CANCER 125
In vitro and in vivo study of a desmopressin nasal powder 124
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)-tartaric acid 124
VALUTAZIONE DELLA COMPOSIZIONE IN AMMINOACIDI DELL' UMORE ACOUEO E DEL PLASMA IN SOGGETTI GLAUCOMATOSI 121
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 120
In vitro comparison of four anti-inflammatory topical medications 116
Spray drying production of trypsin containing microparticles 115
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 115
Development of artemisinin - β-cyclodextrin complex agglomerates 114
Modulation of protease activity by NO-mediated S-nitrosylation. 114
In vitro transport studies across excised nasal mucosa for three drug candidates to nose-to-brain delivery 114
Pullulan-cyclodextrin microspheres - A chromatographic approach for the evaluation of the drug-cyclodextrin interactions and the determination of the drug release profiles 113
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 113
Development of a spray-dried powder for nasal administration of desmopressin acetate 112
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate 112
Diffusion of preservatives from topical dosage forms: A comparative study 111
Liposomes carrying anti herpetic peptides as a tool for a potential ocular vaccine 110
Soft chimera agglomerates for desmopressin nasal administration: an in vitro and in vivo study 108
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 108
Use of sucralfate gel as a vehicle for topical administration of the antiviral drug cidofovir 106
null 106
Desmopressin Dry Powder for Nasal Administration 105
Synthesis and study of 5′-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist 100
Study of a Sucralfate gel-based therapeutic paint for antiviral drug topical application by spraying 100
null 96
null 88
null 85
null 81
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 80
null 79
HIV protease inhibitors: synthesis and activity of N-aryl-N '-hydroxyalkyl hydrazide pseudopeptides 74
Multicomponent antibiotic substances produced by fermentation: Implications for regulatory authorities, critically ill patients and generics 71
In vitro transport studies across rabbit nasal mucosa of a model compound intended for nose-to-brain delivery in post-traumatic stress disorder 62
null 62
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 56
null 51
null 44
Totale 13.089
Categoria #
all - tutte 53.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.304
Totale 54.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021190 0 0 0 0 0 0 0 0 0 0 134 56
2021/2022767 21 98 61 58 19 22 25 51 20 56 71 265
2022/2023819 81 44 20 119 141 129 20 68 111 9 60 17
2023/2024453 45 55 23 12 30 83 16 17 5 23 29 115
2024/20251.769 39 38 131 60 257 202 73 77 279 172 266 175
2025/20264.899 504 248 424 745 649 340 508 336 439 548 158 0
Totale 13.089